Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Tsukuda

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The Journal of Biological Chemistry|January 20, 2005
Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signalingYasumasa Kato, Charles A Lambert, Alain C Colige, et al.
Anticancer Research|January 31, 2012
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinomaMasanori Komatsu, Mamoru Tsukuda, Hideki Matsuda, et al.
International Journal of Oncology|August 4, 2005
Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteineYasumasa Kato, Mamoru Tsukuda, Yoji Nagashima, et al.
Cancer Science|August 14, 2009
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinomaShigeyuki Ozawa, Yasumasa Kato, Shin Ito, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidityMamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
International Journal of Molecular Medicine|July 14, 2005
Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 casesYasumasa Kato, Yoji Nagashima, Yuh Baba, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The Journal of Biological Chemistry|January 20, 2005
Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signalingYasumasa Kato, Charles A Lambert, Alain C Colige, et al.
Anticancer Research|January 31, 2012
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinomaMasanori Komatsu, Mamoru Tsukuda, Hideki Matsuda, et al.
International Journal of Oncology|August 4, 2005
Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteineYasumasa Kato, Mamoru Tsukuda, Yoji Nagashima, et al.
Cancer Science|August 14, 2009
Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinomaShigeyuki Ozawa, Yasumasa Kato, Shin Ito, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2009
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neckMamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, et al.
Nihon Jibiinkoka Gakkai Kaiho|March 16, 2005
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]Hideaki Katori, Mamoru Tsukuda, Junichi Ishitoya, et al.
Cancer Chemotherapy and Pharmacology|February 17, 2009
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidityMamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, et al.
International Journal of Molecular Medicine|July 14, 2005
Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 casesYasumasa Kato, Yoji Nagashima, Yuh Baba, et al.
Pageof 12